Hugo Hämmerle
Amministratore Delegato presso NMI Technologietransfer GmbH
Posizioni attive di Hugo Hämmerle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Retina Implant AG
 Retina Implant AG Medical SpecialtiesHealth Technology Retina Implant AG develops sub retinal implants for partially sighted and blind patients. The company was founded in 2003 and is headquartered in Reutlingen, Germany. | Direttore/Membro del Consiglio | - | - |
| Eberhard Karls Universität Tübingen | Corporate Officer/Principal | - | - |
NMI Technologietransfer GmbH
 NMI Technologietransfer GmbH Miscellaneous Commercial ServicesCommercial Services Part of NMI Naturwissenschaftliches & Medizinisches Institut, NMI Technologietransfer GmbH is a contract research organization that consists of three business units: NMI TT Pharmaservices, NMI TT Testing Services, and NMI TT Microdevices. The company is based in Reutlingen, Germany. NMI TT Pharmaservices offers advanced cell-based assays, novel and better cell models, and custom cell lines for the pharma industry, oncology, academia, and cancer research. Additionally, the German company offers electrophysiology services on different target systems such as heart, brain, and retina. The CEO of the company is Hugo Hämmerle. | Amministratore Delegato | - | - |
Storia della carriera di Hugo Hämmerle
Precedenti posizioni note di Hugo Hämmerle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| STRATEC SE | Direttore/Membro del Consiglio | 18/06/2014 | 18/06/2014 |
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Presidente | 19/05/2010 | - |
| Fondatore | 01/01/2000 | - |
Formazione di Hugo Hämmerle
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| University of Hohenheim | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Germania | 7 |
Posizioni
| Director/Board Member | 2 |
| Chairman | 1 |
| Founder | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| STRATEC SE | Health Technology |
| Aziende private | 3 |
|---|---|
NMI Technologietransfer GmbH
NMI Technologietransfer GmbH Miscellaneous Commercial ServicesCommercial Services Part of NMI Naturwissenschaftliches & Medizinisches Institut, NMI Technologietransfer GmbH is a contract research organization that consists of three business units: NMI TT Pharmaservices, NMI TT Testing Services, and NMI TT Microdevices. The company is based in Reutlingen, Germany. NMI TT Pharmaservices offers advanced cell-based assays, novel and better cell models, and custom cell lines for the pharma industry, oncology, academia, and cancer research. Additionally, the German company offers electrophysiology services on different target systems such as heart, brain, and retina. The CEO of the company is Hugo Hämmerle. | Commercial Services |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Health Technology |
Retina Implant AG
Retina Implant AG Medical SpecialtiesHealth Technology Retina Implant AG develops sub retinal implants for partially sighted and blind patients. The company was founded in 2003 and is headquartered in Reutlingen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Hugo Hämmerle
- Esperienza
